These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3969334)

  • 1. Progressive diaphyseal dysplasia: evaluation of corticosteroid therapy.
    Naveh Y; Alon U; Kaftori JK; Berant M
    Pediatrics; 1985 Feb; 75(2):321-3. PubMed ID: 3969334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and scintigraphic evaluation of corticosteroid treatment in a case of progressive diaphyseal dysplasia.
    Verbruggen LA; Bossuyt A; Schreuer R; Somers G
    J Rheumatol; 1985 Aug; 12(4):809-13. PubMed ID: 4057207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive diaphyseal dysplasia presenting as neuromuscular disease.
    Stenzler S; Grogan DP; Frenchman SM; McClelland S; Ogden JA
    J Pediatr Orthop; 1989; 9(4):463-7. PubMed ID: 2732328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Camurati-Engelmann disease--a rare cause of bone pain.
    Mundra V; Taxel P
    Conn Med; 2012 Jan; 76(1):33-7. PubMed ID: 22372177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Moxley RT; Ashwal S; Pandya S; Connolly A; Florence J; Mathews K; Baumbach L; McDonald C; Sussman M; Wade C; ;
    Neurology; 2005 Jan; 64(1):13-20. PubMed ID: 15642897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive diaphyseal dysplasia: Camurati-Engelmann's disease.
    Lazzarone C; Cartesegna M; Crova M; Calorio D
    Ital J Orthop Traumatol; 1983 Mar; 9(1):109-14. PubMed ID: 6885383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diaphyseal dysplasia (Engelmann) treated with corticosteroids.
    Lindstrom JA
    Birth Defects Orig Artic Ser; 1974; 10(12):504-7. PubMed ID: 4461085
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical, humoral and scintigraphic assessment of a bisphosphonate as potential treatment of diaphyseal dysplasia: Ribbing and Cammurati-Engelmann diseases].
    de Rubin ZS; Ghiringhelli G; Mansur JL
    Medicina (B Aires); 1997; 57 Suppl 1():56-60. PubMed ID: 9567356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghosal hematodiaphyseal dysplasia: a rare cause of a myelophthisic anemia.
    Mazaheri P; Nadkarni G; Lowe E; Hines P; Vuica M; Griffin M; Resar LM
    Pediatr Blood Cancer; 2010 Dec; 55(6):1187-90. PubMed ID: 20672367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deflazacort treatment in progressive diaphyseal dysplasia (Camurati-Engelmann disease).
    Baş F; Darendeliler F; Petorak I; Sadikoğlu B; Bilir A; Bundak R; Saka N; Günöz H
    J Paediatr Child Health; 1999 Aug; 35(4):401-5. PubMed ID: 10457303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Pedrosa MC; Rohrer RM; Kaplan MM
    Clin Transplant; 1995 Aug; 9(4):322-5. PubMed ID: 7579741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive diaphyseal dysplasia (Camurati-Engelmann's disease). Improvement of clinical signs and of bone scintigraphy during pregnancy.
    De Vits A; Keymeulen B; Bossuyt A; Somers G; Verbruggen LA
    Clin Nucl Med; 1994 Feb; 19(2):104-7. PubMed ID: 8187392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintigraphic evaluation of pamidronate and corticosteroid therapy in a patient with progressive diaphyseal dysplasia (Camurati-Engelmann disease).
    Inaoka T; Shuke N; Sato J; Ishikawa Y; Takahashi K; Aburano T; Makita Y
    Clin Nucl Med; 2001 Aug; 26(8):680-2. PubMed ID: 11452173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive diaphyseal dysplasia: a three-generation family with markedly variable expressivity.
    Saraiva JM
    Am J Med Genet; 1997 Aug; 71(3):348-52. PubMed ID: 9268107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment with corticosteroid in a patient with progressive diaphyseal dysplasia.
    Bourantas K; Tsiara S; Drosos AA
    Clin Rheumatol; 1995 Jul; 14(4):485-6. PubMed ID: 7586992
    [No Abstract]   [Full Text] [Related]  

  • 16. Camurati-Engelmann disease type II: progressive diaphyseal dysplasia with striations of the bones.
    Nishimura G; Nishimura H; Tanaka Y; Makita Y; Ikegawa S; Ghadami M; Kinoshita A; Niikawa N
    Am J Med Genet; 2002 Jan; 107(1):5-11. PubMed ID: 11807860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients.
    Pascuzzi RM; Coslett HB; Johns TR
    Ann Neurol; 1984 Mar; 15(3):291-8. PubMed ID: 6721451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Camurati-Engelmann disease. Effects of corticosteroids.
    Heymans O; Gebhart M; Alexiou J; Sokolow Y
    Acta Clin Belg; 1998 Jun; 53(3):189-92. PubMed ID: 9701854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Camurati-Engelmann disease: a case report].
    Almeida J; Beça G; Laíns J
    Acta Reumatol Port; 2013; 38(2):122-6. PubMed ID: 24141349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy.
    McEnery PT; McAdams AJ; West CD
    Clin Nephrol; 1980 Mar; 13(3):117-24. PubMed ID: 7379361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.